Gene · 5641
Papers1,807
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,807
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Identification of Novel Loci Involved in Adalimumab Response in Crohn's Disease Patients Using Integration of Genome Profiling and Isoform-Level Immune-Cell Deconvoluted Transcriptome Profiling of Colon Tissue. | Pharmaceutics | 2022 | 36145641 | PubTator, text mining | PubMed |
| Ozone Infiltration for Osteonecrosis of the Jaw Therapy: A Case Series. | J Clin Med | 2022 | 36142954 | PubTator, text mining | PubMed |
| Roles of Species-Specific Legumains in Pathogenicity of the Pinewood Nematode Bursaphelenchus xylophilus. | Int J Mol Sci | 2022 | 36142347 | PubTator, text mining | PubMed |
| The Asparaginyl Endopeptidase Legumain: An Emerging Therapeutic Target and Potential Biomarker for Alzheimer's Disease. | Int J Mol Sci | 2022 | 36142134 | PubTator, text mining | PubMed |
| New Insights into the Alveolar Epithelium as a Driver of Acute Respiratory Distress Syndrome. | Biomolecules | 2022 | 36139112 | PubTator, text mining | PubMed |
| Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis. | Front Pharmacol | 2022 | 36120344 | PubTator, text mining | PubMed |
| Structural and functional studies of legumain-mycocypin complexes revealed a competitive, exosite-regulated mode of interaction. | J Biol Chem | 2022 | 36116553 | PubTator, text mining | PubMed |
| Changes in the architecture and abundance of replication intermediates delineate the chronology of DNA damage tolerance pathways at UV-stalled replication forks in human cells. | Nucleic Acids Res | 2022 | 36107774 | PubTator, text mining | PubMed |
| Biology of lung macrophages in health and disease. | Immunity | 2022 | 36103853 | PubTator, text mining | PubMed |
| Response by Pan and Sun to Letter Regarding Article, "Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture". | Circulation | 2022 | 36095064 | PubTator, text mining | PubMed |
| Letter by Wang et al Regarding Article, "Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture". | Circulation | 2022 | 36095060 | PubTator, text mining | PubMed |
| A newly identified secreted larval antigen elicits basophil-dependent protective immunity against N. brasiliensis infection. | Front Immunol | 2022 | 36091065 | PubTator, text mining | PubMed |
| Transcriptome analysis of Homo sapiens and Mus musculus reveals mechanisms of CD8+ T cell exhaustion caused by different factors. | PLoS One | 2022 | 36084049 | PubTator, text mining | PubMed |
| The Role of Perineural Invasion in Prostate Cancer and Its Prognostic Significance. | Cancers (Basel) | 2022 | 36077602 | PubTator, text mining | PubMed |
| The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine. | Int J Mol Sci | 2022 | 36077371 | PubTator, text mining | PubMed |
| Interdomain Linker Effect on the Mechanical Stability of Ig Domains in Titin. | Int J Mol Sci | 2022 | 36077234 | PubTator, text mining | PubMed |
| Evaluation of an ester-linked immunosuppressive payload: A case study in understanding the stability and cleavability of ester-containing ADC linkers. | Bioorg Med Chem Lett | 2022 | 36058468 | PubTator, text mining | PubMed |
| Implications of the Essential Role of Small Molecule Ligand Binding Pockets in Protein-Protein Interactions. | J Phys Chem B | 2022 | 36044742 | PubTator, text mining | PubMed |
| Legumain affects the PI3K/AKT tumor progression pathway in retinoblastoma. | Exp Eye Res | 2022 | 36041510 | PubTator, text mining | PubMed |
| Low-dose chest CT for preoperative screening for SARS-CoV-2 infection. | Radiologia (Engl Ed) | 2022 | 36030079 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5641/papers?page=22